Plain-English translation of NCT03807128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →MYRACLE is a long-term research study that follows patients with multiple myeloma — a blood cancer — to understand how the disease develops and why it sometimes stops responding to treatment. Researchers will collect information about your medical history, treatments, and side effects, along with blood samples and biopsies. This information will help doctors discover new ways to predict which treatments will work best for each patient.
Multiple myeloma often becomes resistant to treatment over time, and doctors don't yet have reliable ways to predict which patients will develop this resistance or which new approaches might work. This study aims to find biological markers that could help personalize treatment and improve outcomes.
You likely qualify if…
You likely don't qualify if…
You will be followed continuously at the hospital where you receive your myeloma treatment. During regular visits, your doctors will collect information about your health, the treatments you're receiving, any side effects, and how you're doing. You'll also be asked to complete questionnaires about your quality of life, and to donate blood samples for laboratory analysis. If you have diagnostic biopsies as part of your regular care, those samples will be stored for research. The study continues as long as you're willing to participate.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
France